KCT0000798已完成未知
Bioequivalence of Sam Chun Dang torasemide 20 mg in Korean subjects
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 55(Year)（—）
- 性别
- All
入选标准
- •1. Subjects between the ages of 19 and 55 years
- •2. No History of congenital or chronic disease
- •3. No clinically relevant abnormalities identified by laboratory test, including hematology, blood chemistry, and urinalysis
- •4. Female subject known to be negative for pregnant test
排除标准
- •1. Use of any drugs (Barbitals, alcohol) known to significantly induce or inhibit drug-metabolizing enzymes within 1 month prior to dosing
- •2. Received any drugs within 10 days before the study
- •3. Inappropriate subject for entry into this study in the judgement of the investigator
研究者
相似试验
已完成
不适用
Bioequivalence of Sam Chun Dang torasemide 5 mg in Korean subjectsKCT0000799Chonnam National University28
已完成
不适用
Bioequivalence of torasemide 10 mg in Korean subjectsKCT0000794Chonnam National University28
已完成
不适用
Bioequivalence of torasemide 5 mg in Korean subjectsKCT0000795Chonnam National University28
已完成
不适用
Bioequivalence study of Tamsulosin 0.4 mgIRCT20200623047902N4Sanamed pharma company18
招募中
不适用
Clinical study to compare the in vivo parameters of 2 Tamsulosin 0.4 mg ER Capsule formulationsIRCT20180620040164N28Cosar pharmaceutical Co.24